$FOXO
FOXO TECHNOLOGIES INC.

2022 Q2 Form 10-Q Financial Statement

#000121390022047386 Filed on August 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2021 Q4 2021 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $39.00K
YoY Change
Gross Profit -$39.00K
YoY Change
Gross Profit Margin
Selling, General & Admin $1.174M $523.9K $203.1K
YoY Change 478.01% 1209.8%
% of Gross Profit
Research & Development $1.001M $560.0K
YoY Change
% of Gross Profit
Depreciation & Amortization $90.00K $30.00K $50.00K
YoY Change 80.0%
% of Gross Profit
Operating Expenses $1.174M $523.9K $203.1K
YoY Change 478.01% 1209.8%
Operating Profit -$1.174M -$203.1K
YoY Change 478.02%
Interest Expense $1.042M $1.665M -$1.654M
YoY Change -162.97% -360.13%
% of Operating Profit
Other Income/Expense, Net -$54.00K -$210.0K
YoY Change
Pretax Income -$132.3K $1.141M -$1.857M
YoY Change -92.88% -270.29%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings -$132.3K $1.141M -$1.857M
YoY Change -92.88% -270.29%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$5.659K $44.24K -$72.02K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q2 2021 Q4 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $147.0K $638.2K $1.164M
YoY Change -87.37% -54.41%
Cash & Equivalents $147.0K $638.2K $1.164M
Short-Term Investments
Other Short-Term Assets $126.1K $234.3K $320.3K
YoY Change -60.63% -53.15%
Inventory $1.200M $295.0K
Prepaid Expenses $126.1K $234.3K
Receivables
Other Receivables
Total Short-Term Assets $273.1K $872.5K $1.484M
YoY Change -81.6% -54.08%
LONG-TERM ASSETS
Property, Plant & Equipment $180.0K $187.0K
YoY Change
Goodwill
YoY Change
Intangibles $191.0K
YoY Change
Long-Term Investments $110.9M $201.3M $201.3M
YoY Change -44.91% -0.01%
Other Assets $23.00M
YoY Change
Total Long-Term Assets $110.9M $201.3M $201.3M
YoY Change -44.91% 0.04%
TOTAL ASSETS
Total Short-Term Assets $273.1K $872.5K $1.484M
Total Long-Term Assets $110.9M $201.3M $201.3M
Total Assets $111.2M $202.2M $202.8M
YoY Change -45.18% -0.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.576M $309.5K $35.42K
YoY Change 7173.11%
Accrued Expenses $740.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $946.7K $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.528M $314.5K $40.42K
YoY Change 8627.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.203M $12.13M $14.52M
YoY Change -64.17% -32.97%
Total Long-Term Liabilities $5.203M $12.13M $14.52M
YoY Change -64.17% -32.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.528M $314.5K $40.42K
Total Long-Term Liabilities $5.203M $12.13M $14.52M
Total Liabilities $8.730M $12.45M $14.56M
YoY Change -40.04% -31.23%
SHAREHOLDERS EQUITY
Retained Earnings -$8.458M -$11.58M
YoY Change
Common Stock $63.00 $63.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$8.457M -$11.57M -$13.08M
YoY Change
Total Liabilities & Shareholders Equity $111.2M $202.2M $202.8M
YoY Change -45.18% -0.47%

Cashflow Statement

Concept 2022 Q2 2021 Q4 2021 Q2
OPERATING ACTIVITIES
Net Income -$132.3K $1.141M -$1.857M
YoY Change -92.88% -270.29%
Depreciation, Depletion And Amortization $90.00K $30.00K $50.00K
YoY Change 80.0%
Cash From Operating Activities -$553.7K -$371.3K -$143.4K
YoY Change 286.2% -22.65%
INVESTING ACTIVITIES
Capital Expenditures $1.260M $160.0K $30.00K
YoY Change 4100.0%
Acquisitions
YoY Change
Other Investing Activities $90.55M $0.00 -$50.00K
YoY Change -181205.66% -100.0%
Cash From Investing Activities $90.55M $0.00 -$80.00K
YoY Change -113291.04% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -90.05M 0.000 13.00M
YoY Change -792.66% -100.0%
NET CHANGE
Cash From Operating Activities -553.7K -371.3K -143.4K
Cash From Investing Activities 90.55M 0.000 -80.00K
Cash From Financing Activities -90.05M 0.000 13.00M
Net Change In Cash -46.30K -371.3K -143.4K
YoY Change -67.71% -126.15%
FREE CASH FLOW
Cash From Operating Activities -$553.7K -$371.3K -$143.4K
Capital Expenditures $1.260M $160.0K $30.00K
Free Cash Flow -$1.814M -$531.3K -$173.4K
YoY Change 946.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Type
DocumentType
10-Q
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39783
dei Entity Registrant Name
EntityRegistrantName
DELWINDS INSURANCE ACQUISITION CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Address Address Line1
EntityAddressAddressLine1
One City Centre
dei Entity Address Address Line2
EntityAddressAddressLine2
1021 Main Street
dei Entity Address Address Line3
EntityAddressAddressLine3
Suite 1960
dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77002
dei City Area Code
CityAreaCode
(713)
dei Local Phone Number
LocalPhoneNumber
337-4077
dei Security12b Title
Security12bTitle
Shares of Class A Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
DWIN
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
147023 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
638228 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
126066 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
234258 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
273089 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
872486 usd
CY2022Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
110881364 usd
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
201278924 usd
CY2022Q2 us-gaap Assets
Assets
111154453 usd
CY2021Q4 us-gaap Assets
Assets
202151410 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2576137 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
309483 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
5000 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
5000 usd
CY2022Q2 dwin Note Payable To Foxo
NotePayableToFOXO
386665 usd
CY2022Q2 us-gaap Notes Payable Current
NotesPayableCurrent
560000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3527802 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
314483 usd
CY2022Q2 dwin Deferred Underwriting Commission
DeferredUnderwritingCommission
3021875 usd
CY2021Q4 dwin Deferred Underwriting Commission
DeferredUnderwritingCommission
7043750 usd
CY2022Q2 dwin Warrant Liability
WarrantLiability
2180665 usd
CY2021Q4 dwin Warrant Liability
WarrantLiability
5088750 usd
CY2022Q2 us-gaap Liabilities
Liabilities
8730342 usd
CY2021Q4 us-gaap Liabilities
Liabilities
12446983 usd
CY2022Q2 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
11047578 shares
CY2021Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
20125000 shares
CY2022Q2 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.04
CY2021Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10
CY2022Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
110881364 usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
201278924 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
63 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
63 usd
CY2022Q2 dwin Common Stock Value1
CommonStockValue1
503 usd
CY2021Q4 dwin Common Stock Value1
CommonStockValue1
503 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8457819 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11575063 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-8457253 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-11574497 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
111154453 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
202151410 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1174057 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
203118 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3573487 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
416728 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1174057 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-203118 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3573487 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-416728 usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
112508 usd
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
7194 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
156177 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
20496 usd
CY2022Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-5002 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
1050 usd
CY2022Q2 dwin Change In Fair Value Of Warrant Liability
ChangeInFairValueOfWarrantLiability
-934298 usd
CY2021Q2 dwin Change In Fair Value Of Warrant Liability
ChangeInFairValueOfWarrantLiability
1661506 usd
dwin Change In Fair Value Of Warrant Liability
ChangeInFairValueOfWarrantLiability
-2908085 usd
dwin Change In Fair Value Of Warrant Liability
ChangeInFairValueOfWarrantLiability
-3535100 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-132253 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1857430 usd
us-gaap Net Income Loss
NetIncomeLoss
-509225 usd
us-gaap Net Income Loss
NetIncomeLoss
3139918 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-11574497 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
4021875 usd
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-395406 usd
us-gaap Net Income Loss
NetIncomeLoss
-509225 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-8457253 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-16193994 usd
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
21546 usd
us-gaap Net Income Loss
NetIncomeLoss
3139918 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-13075622 usd
us-gaap Net Income Loss
NetIncomeLoss
-509225 usd
us-gaap Net Income Loss
NetIncomeLoss
3139918 usd
dwin Interest Earned Trust Account
InterestEarnedTrustAccount
156177 usd
dwin Interest Earned Trust Account
InterestEarnedTrustAccount
20496 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
1050 usd
dwin Fair Value Adjustments Of Warrants
FairValueAdjustmentsOfWarrants
2908085 usd
dwin Fair Value Adjustments Of Warrants
FairValueAdjustmentsOfWarrants
3535100 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-108192 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-151307 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
2266654 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
12037 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1198641 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-253384 usd
dwin Cash Deposited In Trust Account
CashDepositedInTrustAccount
386665 usd
dwin Distribution From Trust Account For Taxes
DistributionFromTrustAccountForTaxes
147436 usd
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-90792059 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
90552830 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-90792059 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
386665 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
560000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-89845394 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-491205 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-253384 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
638228 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1417540 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
147023 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1164156 usd
dwin Change In Value Of Common Stock Subject To Redemption
ChangeInValueOfCommonStockSubjectToRedemption
346735 usd
dwin Change In Value Of Common Stock Subject To Redemption
ChangeInValueOfCommonStockSubjectToRedemption
21546 usd
dwin Equity Transaction Costs
EquityTransactionCosts
11494785 usd
us-gaap Expense Related To Distribution Or Servicing And Underwriting Fees
ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
4025000 usd
us-gaap Other Underwriting Expense
OtherUnderwritingExpense
7043750 usd
dwin Other Offering Costs
OtherOfferingCosts
426035 usd
CY2022Q2 us-gaap Cash
Cash
2054942 usd
dwin Percentage Of Fair Market Value
PercentageOfFairMarketValue
0.80 pure
CY2022Q2 dwin Finite Lived Tangible Assets Net
FiniteLivedTangibleAssetsNet
5000001 usd
CY2022Q2 us-gaap Restricted Investments Percent Of Net Assets
RestrictedInvestmentsPercentOfNetAssets
0.15 pure
CY2022Q2 dwin Stockholders Holding Shares
StockholdersHoldingShares
9077422 shares
CY2022Q2 us-gaap Cost Of Trust Assets Sold To Pay Expenses
CostOfTrustAssetsSoldToPayExpenses
90792966.89 usd
CY2022Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10
CY2022Q2 dwin Aggregate Principal Amount Description
AggregatePrincipalAmountDescription
on June 6, 2022, the Company issued a promissory note in the aggregate principal amount of up to $1,159,995.69 to FOXO (the “FOXO Note”), pursuant to which FOXO agreed to loan the Company an aggregate principal amount of up to $1,159,995.69 to be deposited into the Trust Account for each Public Share that was not redeemed in connection with the extension of the Company’s termination date for each month past June 15, 2022 until September 15, 2022, which may be drawn down in three equal amounts of $386,665.23 per withdrawal, between the 15th and 22nd of each of June, July and August 2022. A sum of $386,665.23 was promptly drawn down on the FOXO Note and deposited into the Trust Account to cover the first month of the extension.
CY2022Q2 dwin Price Per Share
PricePerShare
-10
dwin Business Combination Reason For Business Combination1
BusinessCombinationReasonForBusinessCombination1
In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”).
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of the accompanying unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> </p>
dwin Offering Costs Amount
OfferingCostsAmount
11494785 usd
CY2022Q2 dwin Deferred Tax Asset Operating Loss Carryforwards
DeferredTaxAssetOperatingLossCarryforwards
994000 usd
CY2022Q2 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-132253 usd
CY2021Q2 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
1857430 usd
us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-509225 usd
us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
3139918 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-132253 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1857430 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-509225 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3139918 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. At June 30, 2022 and December 31, 2021, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> </p>
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 usd
dwin Stock Issued During Period Share Share Based Compensation Forfeited
StockIssuedDuringPeriodShareShareBasedCompensationForfeited
562500 shares
CY2020Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
300000 usd
CY2020Q4 dwin Notes Payable Relatesd Parties Noncurrent
NotesPayableRelatesdPartiesNoncurrent
141134 usd
CY2022Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2000000 usd
dwin Drawn Down Payment
DrawnDownPayment
560000 usd
us-gaap Payments For Rent
PaymentsForRent
10000 usd
CY2021 dwin Due To Sponsor
DueToSponsor
5000 usd
dwin Due To Sponsor
DueToSponsor
5000 usd
dwin Agreement Amount
AgreementAmount
60000 usd
CY2021 dwin Agreement Amount
AgreementAmount
120000 usd
dwin Underwriting Discount
underwritingDiscount
0.2
dwin Other Underwriting Expenses
OtherUnderwritingExpenses
4025000 usd
dwin Underwriting Agreement Description
UnderwritingAgreementDescription
In addition, the underwriters are entitled to a deferred fee of (i) $0.35 per Unit of the gross proceeds of the initial 20,125,000 Units sold in the Initial Public Offering, or $7,043,750.
CY2022Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
4021875 usd
CY2022Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
10000000 usd
CY2022Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
2180665 usd
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
5088750 usd
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0058 pure
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y5M26D
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.163 pure
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
11.5
CY2020Q4 us-gaap Share Price
SharePrice
9.66
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
dwin Converted Basis Percentage Of Common Stock
ConvertedBasisPercentageOfCommonStock
0.20 pure
dwin Description Of Public Warrants For Redemption
DescriptionOfPublicWarrantsForRedemption
Once the warrants become exercisable, the Company may redeem the Public Warrants:    ● in whole and not in part;     ● at a price of $0.01 per warrant;     ● upon not less than 30 days’ prior written notice of redemption given after the warrants become exercisable; and   ●if, and only if, the reported last sale price of the Company’s Class A common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period commencing once the warrants become exercisable and ending three business days before the Company sends the notice of redemption to the warrant holders.
dwin Business Combination Description
BusinessCombinationDescription
In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the shares of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. 
CY2022Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
994000 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
994000 usd
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-718000 usd
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
718000 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0 pure
dwin Permanent Differencesin Dollars
PermanentDifferencesinDollars
1.20 pure
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1.41 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2021Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
994000 usd
dwin Transaction Agreement
TransactionAgreement
The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to August 15, 2022, the date that the accompanying unaudited condensed financial statements were issued.
CY2022Q3 us-gaap Retail Land Sales Installment Method Sales Value
RetailLandSalesInstallmentMethodSalesValue
386665.23 usd
CY2022Q3 us-gaap Withdrawal From Contract Holders Funds
WithdrawalFromContractHoldersFunds
56028 usd
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2021Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2022Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
usd
CY2021Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
usd
CY2022Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001812360
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd

Files In Submission

Name View Source Status
0001213900-22-047386-index-headers.html Edgar Link pending
0001213900-22-047386-index.html Edgar Link pending
0001213900-22-047386.txt Edgar Link pending
0001213900-22-047386-xbrl.zip Edgar Link pending
dwin-20220630.xsd Edgar Link pending
f10q0622ex31-1_delwinds.htm Edgar Link pending
f10q0622ex31-2_delwinds.htm Edgar Link pending
f10q0622ex32-1_delwinds.htm Edgar Link pending
f10q0622ex32-2_delwinds.htm Edgar Link pending
f10q0622_delwind.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
dwin-20220630_pre.xml Edgar Link unprocessable
dwin-20220630_def.xml Edgar Link unprocessable
dwin-20220630_cal.xml Edgar Link unprocessable
dwin-20220630_lab.xml Edgar Link unprocessable
f10q0622_delwind_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable